Literature DB >> 30806337

Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.

Maria B Misiura1, Jennifer Ciarochi2, Jatin Vaidya3, Jeremy Bockholt3, Hans J Johnson3, Vince D Calhoun1, Jane S Paulsen3, Jessica A Turner1.   

Abstract

OBJECTIVES: Apathy is a debilitating symptom of Huntington's disease (HD) and manifests before motor diagnosis, making it an excellent therapeutic target in the preclinical phase of Huntington's disease (prHD). HD is a neurological genetic disorder characterized by cognitive and motor impairment, and psychiatric abnormalities. Apathy is not well characterized within the prHD. In previous literature, damage to the caudate and putamen has been correlated with increased apathy in other neurodegenerative and movement disorders. The objective of this study was to determine whether apathy severity in individuals with prHD is related to striatum volumes and cognitive control. We hypothesized that, within prHD individuals, striatum volumes and cognitive control scores would be related to apathy.
METHODS: We constructed linear mixed models to analyze striatum volumes and cognitive control, a composite measure that includes tasks assessing with apathy scores from 797 prHD participants. The outcome variable for each model was apathy, and the independent variables for the four separate models were caudate volume, putamen volume, cognitive control score, and motor symptom score. We also included depression as a covariate to ensure that our results were not solely related to mood.
RESULTS: Caudate and putamen volumes, as well as measures of cognitive control, were significantly related to apathy scores even after controlling for depression.
CONCLUSIONS: The behavioral apathy expressed by these individuals was related to regions of the brain commonly associated with isolated apathy, and not a direct result of mood symptoms. (JINS, 2019, 25, 462-469).

Entities:  

Keywords:  Apathy; Basal ganglia diseases; Caudate; Executive function; Huntington disease; Putamen

Mesh:

Year:  2019        PMID: 30806337      PMCID: PMC6711382          DOI: 10.1017/S1355617719000067

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  44 in total

1.  Brain structure in preclinical Huntington's disease.

Authors:  Jane S Paulsen; Vince A Magnotta; Ania E Mikos; Henry L Paulson; Elizabeth Penziner; Nancy C Andreasen; Peg C Nopoulos
Journal:  Biol Psychiatry       Date:  2005-08-22       Impact factor: 13.382

Review 2.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.

Authors:  Richard Levy; Bruno Dubois
Journal:  Cereb Cortex       Date:  2005-10-05       Impact factor: 5.357

3.  Functional role of the basal ganglia in the planning and execution of actions.

Authors:  Oury Monchi; Michael Petrides; Antonio P Strafella; Keith J Worsley; Julien Doyon
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

4.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

5.  Psychomotor, executive, and memory function in preclinical Huntington's disease.

Authors:  J S Snowden; D Craufurd; J Thompson; D Neary
Journal:  J Clin Exp Neuropsychol       Date:  2002-04       Impact factor: 2.475

Review 6.  Apathy and the basal ganglia.

Authors:  Richard Levy; Virginie Czernecki
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

7.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

8.  Cognitive impairment related to apathy in early Huntington's disease.

Authors:  Sophie Baudic; Patrick Maison; Guillaume Dolbeau; Marie-Françoise Boissé; Paolo Bartolomeo; Gianfranco Dalla Barba; Latchezar Traykov; Anne-Catherine Bachoud-Lévi
Journal:  Dement Geriatr Cogn Disord       Date:  2006-02-14       Impact factor: 2.959

Review 9.  Apathy: a neuropsychiatric syndrome.

Authors:  R S Marin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

10.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154

View more
  3 in total

Review 1.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

2.  Dissociable Motivational Deficits in Pre-manifest Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Julie C Stout; Trevor T-J Chong
Journal:  Cell Rep Med       Date:  2020-11-30

3.  Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study.

Authors:  Simone Migliore; Giulia D'Aurizio; Sabrina Maffi; Consuelo Ceccarelli; Giovanni Ristori; Silvia Romano; Anna Castaldo; Caterina Mariotti; Giuseppe Curcio; Ferdinando Squitieri
Journal:  Brain Behav       Date:  2021-06-10       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.